Drug products: Oxytetracyclin-Augensalbe Jenapharm, Oxytetral, Terracortril med polymyxin B, Terracortril med Polymyxin B, Terra-Cortril med polymyxin B, Terracortril®, Terracortril® med Polymyxin B, Terramycin®-polymyxin B, Terramycin-Polymyxin B
ATC code: D06AA03, D07CA01, J01AA06, S01AA04, S03CA04
Substances: oxytetracycline, oxytetracycline calcium, oxytetracycline dihydrate, oxytetracycline hydrochloride
Published controlled studies on differences between men and women regarding efficacy, safety and pharmacokinetics of oxytetracycline are lacking.
The present evidence concerning differences between men and women is limited and do not motivate differentiation in dosing or treatment.
No studies with a clinical relevant sex analysis regarding the pharmacokinetics or dosing of oxytetracycline have been found.
No studies with a clinical relevant sex analysis regarding the effects of oxytetracycline have been found.
No studies with a clinical relevant sex analysis regarding the adverse effects of oxytetracycline have been found.
Regarding teratogenic aspects, please consult the Drugs and Birth Defects Database (in Swedish, Janusmed fosterpåverkan).
Date of litterature search: 2015-10-20
Reviewed by: Mia von Euler
Approved by: Karin Schenck-Gustafsson